Mucin expression in pancreatic ductal adenocarcinoma cell lines in 2D and 3D cultures: A proteomic and immunocytochemical analysis
Open Access
- 16 July 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0353991
Abstract
Pancreatic ductal adenocarcinoma (PDAC) exhibits diverse phenotypes, including epithelial and mesenchymal characteristics, yet these features have not been effectively translated into clinical applications. Mucins are implicated in tumor progression and therapeutic resistance and are considered potential diagnostic and therapeutic targets. In this study, five epithelial and three mesenchymal PDAC cell lines were cultured under two-dimensional (2D) and three-dimensional (3D) conditions to investigate mucin expression. Proteomic analysis identified five mucins (MUC1, MUC4, MUC5B, MUC19, and MUC20) in 2D culture and eight (including MUC2, MUC5AC, and MUC13) in 3D culture. Candidate mucins were further validated by immunocytochemistry with H-score assessment. MUC1 was consistently expressed in all PDAC cell lines and showed marked upregulation in several lines under 3D culture. In mesenchymal PDAC cell lines, mucin expression was largely restricted to MUC1, whereas epithelial lines displayed broad 3D-induced reorganization. Notably, MUC5AC was absent in 2D culture but robustly induced in all epithelial PDAC cell lines under 3D conditions. Other mucins, including MUC2, MUC4, MUC5B, MUC13, MUC19, and MUC20, were variably upregulated, with epithelial lines demonstrating higher diversity and intensity of expression. These findings demonstrate that 3D culture effectively reveals the plasticity and heterogeneity of mucin expression in PDAC, highlighting its potential as a platform for biomarker discovery and the development of therapeutic strategies.Keywords
Funding Information
- Japan Society for the Promotion of Science (24K11881)
- Japan Society for the Promotion of Science (25K12018)
- Japan Society for the Promotion of Science (22K08835)
- Japan Society for the Promotion of Science (22K08882)
This publication has 49 references indexed in Scilit:
- Mucins as anti-cancer targets: perspectives of the glycobiologistGlycoconjugate Journal, 2021
- 3D tumor spheroids: an overview on the tools and techniques used for their analysisBiotechnology Advances, 2016
- Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast CancerJAMA Oncology, 2015
- Radioimmunotherapy—a potential novel tool for pancreatic cancer therapy?Tumor Biology, 2015
- The MUC1 oncomucin regulates pancreatic cancer cell biological properties and chemoresistance. Implication of p42–44 MAPK, Akt, Bcl-2 and MMP13 pathwaysBiochemical and Biophysical Research Communications, 2015
- Significance of mucin expression in pancreatobiliary neoplasmsJournal of Hepato-Biliary-Pancreatic Sciences, 2009
- Hypoxia enhances MUC1 expression in a lung adenocarcinoma cell lineBiochemical and Biophysical Research Communications, 2009
- Recent insights into the biological roles of mucin-type O-glycosylationGlycoconjugate Journal, 2008
- Intraductal papillary‐mucinous neoplasms of the pancreasCancer, 2001
- Effect of glycosylation of a synthetic MUC1 mucin-core-related peptide on recognition by anti-mucin antibodiesCancer Letters, 1996